![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Integrity Applications Advances in FDA Approval Process for GlucoTrack
Integrity Applications Advances in FDA Approval Process for GlucoTrack
![Integrity Applications Logo](https://www.fdanews.com/ext/resources/test/Device_Images5/integrity.png?t=1579739023&width=430)
Integrity Applications announced that it has met with the FDA to discuss clinical trial protocol for its GlucoTrack Model DF-F.
GlucoTrack is a non-invasive device designed for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes.
The company submitted pre-submission documents to the FDA in August, including the U.S. clinical trial protocol.
Integrity expects to begin clinical trials in the United States in early 2016. — Michael Cipriano
Upcoming Events
-
11Jul
-
18Jul
-
21Oct